Alexandria Real Estate Equities, Inc. has delivered a 427,000-square-foot research & development hub for Bristol Myers Squibb (BMS) at the Campus Point by Alexandria Megacampus in San Diego. Since 1998, Alexandria has partnered with BMS across the REIT’s life science and advanced technology clusters.
The initial phase of Campus Point was launched in 2010, 16 years after the then-fledgling company made its first acquisition in San Diego. As of March 31, 2026, Campus Point was 95.4% occupied and spans 2.9 million square feet, including 1.3 million square feet in operation, 0.9 million square feet under construction and 0.7 million square feet available for future development and redevelopment.
“Strategically designed to accelerate innovation, Campus Point provides tenants with the flexibility to expand within the same Megacampus ecosystem while helping them recruit and retain top talent, translate research into life-changing treatments with mission-critical infrastructure and leverage key industry relationships,” said Bret Gossett, EVP – co-regional market director and head of leasing for the San Diego region at Alexandria.
The post Alexandria Delivers R&D Hub for Bristol Myers Squibb at San Diego Megacampus appeared first on Connect CRE.
